Quan Capital is a life sciences venture firm with global vision and capabilities combined with unique China strengths. It invests in innovative early and growth stage life sciences companies, with primary focus on therapeutics and related areas including enabling technologies and high-end services, etc. The Quan team is led by seasoned investment professionals with strong track record of consistently high returns. They are highly successful company builders with deep industry knowledge across biopharma value chain. With presence in both China and US, Quan leverages its expertise in cross-border value creation with strong local execution capabilities.
View Top Employees from Quan Capital 泉创资本Website | http://www.quancapital.com |
Revenue | $5 million |
Employees | 15 (10 on RocketReach) |
Founded | 2017 |
Industry | Investment Management, Law Firms & Legal Services |
SIC | SIC Code 679 Companies, SIC Code 67 Companies |
NAICS | NAICS Code 52 Companies, NAICS Code 5239 Companies, NAICS Code 523 Companies |
Looking for a particular Quan Capital 泉创资本 employee's phone or email?
The Quan Capital 泉创资本 annual revenue was $5 million in 2024.
Marietta Wu is the Managing Director of Quan Capital 泉创资本.
10 people are employed at Quan Capital 泉创资本.
The NAICS codes for Quan Capital 泉创资本 are [52, 5239, 523].
The SIC codes for Quan Capital 泉创资本 are [679, 67].